Abbott India Ltd.

26663.80 -84.65 ▼-0.3%

28 March 2024, 04:01:00 PM
Volume: 555

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.abbott.co.in
Market Cap 57,527.70 Cr.
Enterprise Value(EV) 54,887.04 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 539.11 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 50.22 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 1,609.42 Trailing Twelve Months Ending 2023-12
Price to Book Value 16.82 Calculated using Price: 27,072.75
Dividend Yield 1.20 Period Ending 2023-03
No. of Shares Subscribed 2.12 Cr. 21,249,302 Shares
FaceValue 10
About Abbott India Ltd.
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.

Abbott India Ltd. Delivery

Delivered Qty
Traded Qty

Abbott India Ltd. Performance

1 Day
-0.32%
1 Week
-3.63%
1 Month
-6.90%
3 Month
+18.16%
6 Month
+17.67%
1 Year
+24.44%
2 Year
+66.23%
5 Year
+267.20%
10 Year
+1459.15%

Abbott India Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 26.54 23.93 21.54 26.35 24.66 27.09 27.89 29.95 32.07
Return on Capital Employed (%) 39.98 37.55 33.96 40.61 37.88 36.54 37.52 40.53 42.93
Return on Assets (%) 11.2 13.39 15.12 18.01 16.9 18.36 18.78 19.89 21.71

Abbott India Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 938 1,196 1,387 1,693 2,009 2,432 2,602 2,820 3,189 3,109
Non Curr. Liab. 432 29 35 41 62 210 190 184 144 140
Curr. Liab. 834 382 632 668 857 891 1,031 1,203 1,206 1,247
Minority Int.
Equity & Liab. 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207 4,539 4,496
Non Curr. Assets 541 156 160 136 167 328 335 354 1,513 1,545
Curr. Assets 1,663 1,451 1,893 2,231 2,761 3,205 3,487 3,853 3,025 2,951
Misc. Exp. not W/O
Total Assets 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207 4,539 4,496

Abbott India Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 2,289 2,615 2,903 3,299 3,679 4,093 4,310 4,913 5,349 5,753
Other Income 48 51 60 118 114 115 83 83 154 217
Total Income 2,338 2,666 2,963 3,417 3,793 4,208 4,393 4,997 5,503 5,970
Total Expenditure -1,978 -2,251 -2,508 -2,775 -3,075 -3,337 -3,391 -3,832 -4,143 -4,350
PBIDT 360 415 455 641 718 871 1,002 1,165 1,360 1,620
Interest -1 -3 -2 -4 -2 -9 -18 -19 -16 -14
Depreciation -15 -14 -16 -16 -17 -60 -58 -66 -70 -70
Taxation -115 -143 -160 -220 -249 -210 -235 -281 -324 -391
Exceptional Items
PAT 229 255 277 401 450 593 691 799 949 1,146
Adjusted EPS 108 120 130 189 212 279 325 376 447 539

Abbott India Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 155 215 249 307 153 499 626 727 948 893
Cash Fr. Inv. -144 -187 -77 -155 -215 -257 -401 -72 -396 -148
Cash Fr. Finan. -42 -58 -80 -90 -102 -143 -217 -582 -637 -639
Net Change -31 -30 91 62 -165 99 8 73 -86 107
Cash & Cash Eqvt 79 49 140 202 38 137 145 218 133 240

Abbott India Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
Public 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Abbott India Ltd. Announcements

Wed, 27 Mar 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the advertisement published in Business Standard (All Editions in English) and Loksatta (in Marathi) today i.e. Wednesday March 27 2024 confirming the dispatch of Postal Ballot Notice through email process for registration of email addresses and information for remote e-voting.
Wed, 27 Mar 2024
Intimation Under Regulation 30
Intimation under Regulation 30
Tue, 26 Mar 2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of the Postal Ballot Notice dated March 13 2024 along with the Explanatory Statement and e-voting instructions for seeking approval of the Members for the Ordinary Resolutions as set out in the Postal Ballot Notice by way of electronic voting. This is for your information and records.

Abbott India Ltd. Technical Scans

Wed, 27 Mar 2024
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Week Low Close Below Last Week Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Abbott India Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 385,837.06 1,620.50 +0.8%
Cipla Ltd. 118,376.16 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 100,885.01 6,171.85 +2.0%
Zydus Lifesciences Ltd. 100,583.15 1,007.35 +0.8%
Mankind Pharma Ltd. 93,457.28 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 89,582.15 6,347.35 +1.9%
Divi's Laboratories Ltd. 89,323.54 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.32 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 31.92 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.82 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 54.11 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.49 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 64.59 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.18 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.57 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.75 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.20 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.52 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.26 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 6.85 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Abbott India Ltd. FAQ's

What is Abbott India share price?

Can I buy Abbott India shares now?

What is the Dividend Yield of Abbott India?

What is the Market Cap of Abbott India?

What are the key metrics to analyse Abbott India?

What is the 52 Week High and Low of Abbott India?

What is the trend of Abbott India share price?